1. E-Tunnel acquisition closes - On 21 May 2026 IDream completed the 100% acquisition of South Korean biometric firm E-Tunnel Inc. for ₹266.4 crore via a share swap, with BSE listing approval received on 20 June 2026. E-Tunnel brings patented finger-vein authentication technology and a proprietary AI platform already generating ₹21.14 Crore in CY2024 revenue, giving IDream an immediate operating business at roughly 1.6% of its current market cap.
2. Promoter cash infusion - Northvale Capital Partners subscribed to 40,00,000 equity shares at ₹10 each for ₹4 crore in cash on 21 May 2026, with listing approval on 20 June 2026. The infusion provides working capital to a company that reported negative EBITDA of ₹2.78 crore and negligible revenue, funding the restart of operations.
3. Management targets re-commencement of film infrastructure business - The company states it is actively identifying avenues to re-commence its core film infrastructure and media services activities, citing a sector projected to reach ₹3.5 trillion by 2026. Any resumption of the legacy business would layer incremental revenue onto the newly acquired biometrics operation.
4. Board approves ₹500 crore investment capacity - The Board has approved an increase in the Section 186 investment, loan, and guarantee limit to ₹500 crore, subject to shareholder approval. The expanded headroom signals intent to deploy capital for further acquisitions or organic expansion beyond the E-Tunnel transaction.
5. Authorised capital raised to ₹275 crore - Members approved an increase in authorised share capital from ₹6.5 crore to ₹275 crore on 27 January 2026, effective upon ROC approval. The enlarged authorised capital accommodates the E-Tunnel share issuance and leaves room for future equity-funded transactions without requiring further structural amendments.
6. Acquirer reserves right to restructure and expand - Post open offer, Northvale and PACs reserved the right to streamline operations through arrangements, restructuring, buybacks, mergers, demergers, or asset sales, and to carry on additional businesses for commercial reasons. This creates a pathway for further corporate action that could reshape the company’s asset base and earnings profile.